Isconova AB
Records under this name other than patents Isconova AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Isconova AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,736,958 | Influenza Vaccine Formerly held In force · High confidence | In force | High confidence | |
| US 10,485,863 | Influenza Vaccine Formerly held In force · High confidence | In force | High confidence | |
| US 10,729,764 | Iscom Preparation and Use Thereof Formerly held Term ended Term ended Nov 5, 2026 · Medium confidence | Term ended | Term ended Nov 5, 2026 | Medium confidence |
| US 8,007,806 | Vaccine Composition Comprising a Fibronectin Binding Protein or a Fibronectin Binding Peptide Term ended Term ended Nov 1, 2026 · High confidence | Term ended | Term ended Nov 1, 2026 | High confidence |
| US 8,821,881 | Quil a Fraction with Low Toxicity and Use Thereof Formerly held Term ended Term ended Aug 19, 2026 · High confidence | Term ended | Term ended Aug 19, 2026 | High confidence |
| US 8,187,585 | Vaccine Composition Comprising a Fibronectin Binding Protein or a Fibronectin Binding Peptide Formerly held Term ended Term ended Jan 20, 2026 · High confidence | Term ended | Term ended Jan 20, 2026 | High confidence |
| US 7,838,019 | Composition Comprising Iscom Particles and Live Micro-Organisms Formerly held Term ended Term ended Jun 29, 2024 · High confidence | Term ended | Term ended Jun 29, 2024 | High confidence |
| US 7,713,942 | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides Lapsed on the fee record Ended May 11, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 11, 2018 | From the USPTO record |